Dawn Phillips - Alexion | 人才画像

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 50 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

RGX-121 Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study

D. R. Blair,P. Harmatz,C. Ficicioglu,R. Giugliani,D. S. Rajan,J. Hagood,M. Fiscella,L. Yang,M. Gilmor,Y. Cho, C. Mulatya,D. Phillips,P. Falabella, L. Pisani

JOURNAL OF INVESTIGATIVE MEDICINE（2024）

引用1浏览0引用

Audiology Assessment of Participants in CAMPSIITE™, a Phase I/II/III Study of RGX-121 in Neuronopathic MPS II

Nidal Boulos,Patricia Roush, Ariana Pjetri,Dawn Phillips, Laura Rosa Pisani,Paulo Falabella

Molecular genetics and metabolismno. 2 (2024): 107776-107776

引用0浏览0引用

RGX-202, an Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy: Interim Clinical Data (S21.005)

Aravindhan Veerapandiyan,Vamshi Rao,Jahannaz Dastgir,Paulo Falabella, Steve Pakola, Sarang Rastogi,Dawn Phillips, Catherine Wilson,Nidal Boulos,Michelle Gilmor,Lin Yang,Hiren Patel,Michele Fiscella,Olivier Danos

Neurologyno. 17_supplement_1 (2024)

引用0浏览0引用

Audiology assessment of participants in CAMPSIITET, a phase I/II/ III study of RGX-121 in neuronopathic MPS II

Nidal Boulos,Patricia Roush, Ariana Pjetri,Dawn Phillips,Laura Pisani,Paulo Falabella

MOLECULAR GENETICS AND METABOLISMno. 2 (2024)

引用0浏览0引用

Daily Living Skills on the Vineland Adaptive Behavioral Scale Version 2 (VABS-II) in Neuronopathic Mucopolysaccharidosis Type II (MPS II)

Dawn Phillips,Yoonjin Cho,Caroline Mulatya, Catherine Wilson,Joseph Hagood,Paulo Falabella

Molecular genetics and metabolismno. 2 (2023): 107268-107268

引用0浏览0引用

The Relationship Between the Expanded Neuronal Ceroid Lipofuscinosis 2 (CLN2) Clinical Rating Scale for Motor Function (CLN2 CRS-MX) and GAITRite® Parameters

Luca Hagenah,Christoph Schwering, Catherine Wilson,Eva Wibbeler,Lena Marie Westermann,Yoonjin Cho,Miriam Nickel,Angela Schulz,Dawn Phillips

Molecular genetics and metabolismno. 2 (2023): 107135-107135

引用0浏览0引用

RGX-111 GENE THERAPY FOR THE TREATMENT OF SEVERE MUCOPOLYSACCHARIDOSIS TYPE I (MPS I): INTERIM ANALYSIS OF DATA FROM THE FIRST IN HUMAN STUDY

Michelle Gilmor,Raymond Wang,Can Ficicioglu,Roberto Giugliani,Jenna Burke, Michele Fiscella,Lin Yang,Dawn Phillips,Paulo Falabella

Molecular Genetics and Metabolismno. 3 (2023): 107416-107416

引用0浏览0引用

Quantifying and Modelling Disease Progression Trajectory for Natural History of MPS II

Yoonjin Cho,Caroline Mulatya,John Zhong,Dawn Phillips,Mark Forsberg

Molecular genetics and metabolism（2023）

引用0浏览0引用

The expanded neuronal ceroid lipofuscinosis 2 (CLN2) clinical rating scale for motor and language function: Development and inter-rater reliability

Dawn Phillips,Yoonjin Cho,Marie-Laure Nevoret,Michelle Wood,Miriam Nickel,Christoph Schwering,Lena Marie Westermann,Angela Schulz

MOLECULAR GENETICS AND METABOLISM（2022）

引用0浏览0引用

NATURAL HISTORY OF NEURODEVELOPMENT IN NEURONOPATHIC MUCOPOLYSACCHARIDOSIS TYPE II (MPS II): MULLEN SCALES OF EARLY LEARNING (MSEL) COGNITIVE, MOTOR AND LANGUAGE DEVELOPMENTAL TRAJECTORIES

Dawn Phillips,Yoonjin Cho,Caroline Mulatya,Marie-Laure Nevoret,Michele Poe,Maria Escolar

Molecular Genetics and Metabolismno. 4 (2022): 293-293

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn